title: Prognostic implication of immunodetection of P glycoprotein in Ewing's sarcoma.
abstract: Increased expression of P glycoprotein is associated with multidrug resistance in many cell lines. P glycoprotein has been detected in different human tumors. To assess the implication of multidrug resistance in the prognosis of Ewing's sarcoma the expression of P glycoprotein was studied immunohistochemically in pre- and post-therapeutic tumor tissues of 21 cases treated according to the CESS 81 or 86 protocol. The response to chemotherapy was evaluated histologically. Formalin-fixed, paraffin-embedded and fresh frozen sections were immunostained with a monoclonal antibody to P glycoprotein, clone JSB 1, using the double APAAP method. P glycoprotein was detected in 12 cases of 21 (57%) in either pre- or postchemotherapy tumor tissues. From the 21 cases 8 revealed a good morphological response to chemotherapy (33%); 10 of the 13 non-responders were positive for P glycoprotein (77%), but only 2 of the 8 responders (25%). The difference was statistically significant (P < 0.05). Comparing P glycoprotein expression with the clinical outcome, we found that 7 of 12 positive cases had died (58%). From the negative cases only 3 of 9 had died (33%). However, judged by the Kaplan Meyer life tables, these data were not significant. In conclusion our results suggest that the immunodetection of P glycoprotein indicates a poor response to chemotherapy and probably a bad clinical outcome for Ewing's sarcoma patients.
authors.affiliation: Gerhard-Domagk-Institut für Pathologie, Münster, Federal Republic of Germany.
authors.forename: A
authors.initials: A
authors.lastname: Roessner
authors.forename: Y
authors.initials: Y
authors.lastname: Ueda
authors.forename: B
authors.initials: B
authors.lastname: Bockhorn-Dworniczak
authors.forename: S
authors.initials: S
authors.lastname: Blasius
authors.forename: A
authors.initials: A
authors.lastname: Peters
authors.forename: P
authors.initials: P
authors.lastname: Wuisman
authors.forename: J
authors.initials: J
authors.lastname: Ritter
authors.forename: M
authors.initials: M
authors.lastname: Paulussen
authors.forename: H
authors.initials: H
authors.lastname: Jürgens
authors.forename: W
authors.initials: W
authors.lastname: Böcker
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology; D001859:Bone Neoplasms / Q000276:immunology* / Q000401:mortality* / Q000473:pathology; D002352:Carrier Proteins / Q000032:analysis* / Q000276:immunology; D002648:Child; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis* / Q000276:immunology; D011379:Prognosis; D012512:Sarcoma, Ewing / Q000276:immunology / Q000401:mortality* / Q000473:pathology
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D002352:Carrier Proteins; D008562:Membrane Glycoproteins